Cargando…
Factors Contributing to the Preference of Korean Patients with Crohn’s Disease When Selecting an Anti-Tumor Necrosis Factor Agent (CHOICE Study)
BACKGROUND/AIMS: Two comparable anti-tumor necrosis factor (TNF) agents with different routes of administration (intravenous [iv] infliximab [IFX] vs subcutaneous [sc] adalimumab [ADA]) are available for patients with Crohn’s disease (CD) in Korea. This study aimed to identify the preferences of Kor...
Autores principales: | Kim, Eun Soo, Kim, Kyeong Ok, Jang, Byung Ik, Lee, Chang Kyun, Kim, Hyo Jong, Lee, Kang-Moon, Kim, You Sun, Eun, Chang Soo, Jung, Sung-Ae, Yang, Suk-Kyun, Lee, Jun, Kim, Tae-Oh, Jung, Yunho, Seo, Geom Seog, Yoon, Soon Man |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of Gut and Liver
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849692/ https://www.ncbi.nlm.nih.gov/pubmed/26347512 http://dx.doi.org/10.5009/gnl15126 |
Ejemplares similares
-
Risk Factors for Postoperative Recurrence in Korean Patients with Crohn’s Disease
por: Kim, Sung Bae, et al.
Publicado: (2020) -
Development of a Clinical and Genetic Prediction Model for Early Intestinal Resection in Patients with Crohn’s Disease: Results from the IMPACT Study
por: Kang, Eun Ae, et al.
Publicado: (2021) -
Influence of anti-tumor necrosis factor-alpha therapy to pregnant inflammatory bowel disease women and their children’s immunity
por: Lee, Ko Eun, et al.
Publicado: (2019) -
Clinical Features and Long-term Prognosis of Crohn’s Disease in Korea: Results from the Prospective CONNECT Study
por: Hong, Seung Wook, et al.
Publicado: (2022) -
Continued Postoperative Use of Tumor Necrosis Factor-α Inhibitors for the Prevention of Crohn’s Disease Recurrence
por: Yu, Jongwook, et al.
Publicado: (2022)